- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: cyclin dependent kinase
Total 12703 results
-
Eli Lilly and CompanyNot yet recruiting
-
M.D. Anderson Cancer CenterNot yet recruitingHormone Receptor-positive Human Epidermal Growth Factor 2-negative | Metastatic Invasive LObular CarcinomaUnited States
-
Region Örebro CountyHelsinki University Central Hospital; Hospital Clinic of Barcelona; University... and other collaboratorsRecruitingQuality of Life | Advanced Breast Cancer | Metastatic Breast Cancer | Toxicity | Older PatientsSweden, Finland, Greece, Italy, Norway, Spain
-
PfizerRecruitingHealthy ParticipantsUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingMelanoma | Kidney Cancer | Breast Cancer | Gastric Cancer | Lung Cancer | Bladder Cancer | Skin Cancer | Head Neck CancerItaly
-
G1 Therapeutics, Inc.RecruitingExtensive-stage Small-cell Lung CancerSpain, Greece, Turkey, Poland, Georgia, Austria, Belgium, Bulgaria, Germany, Hungary
-
Assiut UniversityNot yet recruiting
-
University of MiamiRecruitingBreast Cancer | Metastatic Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
Incyclix BioRecruitingBreast Cancer | Ovarian Cancer | Solid Tumor | Metastatic Cancer | Advanced Cancer | Breast Cancer Metastatic | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | CCNE1 AmplificationUnited States, Australia
-
Prelude TherapeuticsBeiGeneRecruitingT-cell Lymphoma | Mantle Cell Lymphoma (MCL) | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Richter's Syndrome | Aggressive B-Cell Non-Hodgkin's Lymphoma | Aggressive B-Cell NHLUnited States, Canada, Korea, Republic of, Australia, France, Poland, Italy, Germany, Switzerland, United Kingdom
-
PfizerRecruitingBreast Cancer | Solid TumorsChina, United States, Mexico, Bulgaria, Spain, Brazil, Czechia, Argentina, South Africa
-
Medical University of GdanskNot yet recruitingTriple Negative Breast NeoplasmsPoland
-
Namik Kemal UniversityNot yet recruitingCan the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 InhibitorsTurkey
-
National Cancer Institute (NCI)RecruitingKaposi SarcomaUnited States
-
National Cancer Institute (NCI)RecruitingNeurofibromatosis 1United States
-
Medical College of WisconsinRecruitingSoft Tissue Sarcoma | Osteosarcoma | ChondrosarcomaUnited States
-
Montefiore Medical CenterRecruiting
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Safeway FoundationRecruiting
-
PfizerActive, not recruitingBreast Cancer | Small Cell Lung Cancer | Ovarian CancerUnited States, China, Japan, Mexico, Bulgaria, Argentina
-
PfizerCompletedHealthy ParticipantsNetherlands
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Unresectable Solid NeoplasmUnited States
-
Eli Lilly and CompanyNSABP Foundation IncActive, not recruitingBreast CancerUnited States, Spain, China, Germany, Taiwan, United Kingdom, Canada, Singapore, Italy, Australia, Japan, Hungary, Russian Federation, Belgium, New Zealand, Austria, India, Saudi Arabia, France, Czechia, Korea, Republic of, Finland, Argentin... and more
-
Eli Lilly and CompanyActive, not recruitingUrogenital Neoplasms | Prostatic Neoplasms | Neoplasm Metastasis | Enzyme Inhibitors | Antineoplastic Agents | Hormones | Physiological Effects of Drugs | Antineoplastic Agents, Hormonal | Androgens | Hormones, Hormone Substitutes, and Hormone Antagonists | Abiraterone Acetate | Steroid Synthesis Inhibitors | Cytochrome... and other conditionsChina, Canada, France, United States, Australia, Czechia, Hungary, Spain, Germany, Japan, Taiwan, Netherlands, Mexico, Belgium, Korea, Republic of, Turkey, Argentina, Romania, United Kingdom, Italy, Israel, Brazil, Poland, Greece
-
SOLTI Breast Cancer Research GroupMerck Sharp & Dohme LLCActive, not recruiting
-
University of Milano BicoccaCompleted
-
PfizerCompleted
-
G1 Therapeutics, Inc.TerminatedBladder Cancer | Urothelial Carcinoma | Chemotherapy-induced Neutropenia | Myelosuppression Adult | Metastatic Bladder CancerHungary, Spain, United States, France, Georgia
-
G1 Therapeutics, Inc.CompletedBreast Cancer | Triple Negative Breast CancerUnited States
-
Incyte CorporationActive, not recruitingCervical Cancer | Nasopharyngeal Carcinoma | Advanced Solid Tumors | Mesothelioma | Small-cell Lung Cancer | Esophageal Squamous Cell Carcinoma | Merkel Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Anal Carcinoma | Cutaneous Squamous Cell Carcinoma | MSI-H/dMMR Tumors | PD-L1 Amplified Tumor (9p24.1) | Urothelial... and other conditionsFinland, United States, United Kingdom, Belgium, Sweden, Denmark, Norway
-
Loulou FoundationActive, not recruitingCyclin-Dependent Kinase-Like 5 Deficiency DisorderUnited States, Spain, Italy, France, Canada, Germany, United Arab Emirates
-
Cyclacel Pharmaceuticals, Inc.Completed
-
Prelude TherapeuticsActive, not recruitingSarcoma | Breast Cancer | Glioblastoma | Malignant Mesothelioma | Endometrial Cancer | Head and Neck Squamous Cell Carcinoma | Non-small Cell Lung CancersUnited States, Singapore
-
G1 Therapeutics, Inc.Active, not recruitingBreast Cancer | TNBC - Triple-Negative Breast CancerUnited States, Spain, China, France, Australia, Georgia, Poland, Bulgaria, Moldova, Republic of, Russian Federation, Ukraine
-
PfizerActive, not recruitingHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerUnited States, Japan, Canada, Russian Federation, Bulgaria, Ukraine
-
Prelude TherapeuticsCompletedSarcoma | Non-small Cell Lung Cancer | Castrate Resistant Prostate Cancer | Solid Tumors With Known MYC Amplification | Hormone Receptor Positive HER2 Negative Breast CancerUnited States
-
PfizerWithdrawnBreast Cancer | Ovarian Cancer | Non-small Cell Lung Cancer (NSCLC) | Solid Tumors | Liposarcoma | Endometrial
-
G1 Therapeutics, Inc.TerminatedNSCLC | Lung Cancer | Metastatic Non-Small Cell Lung CancerUnited States
-
G1 Therapeutics, Inc.TerminatedColorectal Cancer Metastatic | Chemotherapeutic Toxicity | Myelosuppression-AdultChina, Spain, United States, Hungary, United Kingdom, Poland, Ukraine, Italy
-
PfizerCompletedMetastatic Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedHR+ HER2- Men, Pre/Postmenopausal Advanced Breast CancerCanada
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
TakedaOvid Therapeutics Inc.Completed15q Duplication Syndrome | CDKL5 Deficiency DiseaseUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompletedBreast Cancer | Breast Cancer - Female | Breast Cancer - MaleUnited States
-
PfizerCompletedHealthy ParticipantsUnited States
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | Estrogen Receptor Positive TumorSweden
-
University of Alabama at BirminghamTerminatedHead and Neck CancerUnited States
-
BayerTerminatedSmall Cell Lung CarcinomaUnited States, Korea, Republic of, France
-
G1 Therapeutics, Inc.Bionical EmasApproved for marketingSmall Cell Lung Cancer | Chemotherapeutic Toxicity | Myelosuppression Adult
-
Abramson Cancer Center of the University of PennsylvaniaCompletedAdult Solid Tumor | HER2-positive Breast Cancer | Recurrent Melanoma | Male Breast Cancer | Stage IV Breast Cancer | Stage IV Melanoma | Stage IV Ovarian Germ Cell Tumor | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative... and other conditionsUnited States
-
PfizerCompletedNeoplasms | Breast NeoplasmsJapan